News - Lymphoma Canada

News

Supporting Young Adults with Lymphoma in Canada

In 2012, Lymphoma Canada (LC) donated $14,000 to Young Adults Cancer Canada (YACC), a donation…

adminApril 3, 2013

News

Watchful Waiting

While not beginning immediate treatment can sometimes be challenging for people, research has shown that…

adminApril 3, 2013

News

Continued Support of Lymphoma Research

Donations are the driving force that allows Lymphoma Canada (LC) to move forward in providing…

adminApril 3, 2013

News

Early Detection of Lymphoma in Primary Care

Most Canadians rely on their Primary Care Physician (PCP) to be educated in all medical…

adminApril 3, 2013

News

Canadian Institute for Health Research doubles gifts to LC

Do you believe things happen for a reason? I would like to share with you…

lauradMarch 15, 2013

News

Celebrating Health Canada’s Approval of ADCETRIS

Lymphoma Canada celebrates Health Canada’s Approval of ADCETRIS (Brentuximab Vedotin)

lauradFebruary 13, 2013

Research

Bendamustine for treatment of iNHL and MCL

Lymphoma is the fifth most common malignancy in Canada that is expected to cause 2800…

lauradDecember 1, 2012

Research

Rituximab and Elderly Mantle Cell Patients

A study published in the New England Journal of Medicine showed that maintenance theraphy with…

lauradDecember 1, 2012

Research

Bendamustine added to BC Drug Benefit List

The BC Cancer Agency, in the November 2012 Systemic Therapy Update, has added bendamustine (Treanda®)…

lauradNovember 13, 2012

Research

New Treatment Option for Relapsed Indolent B-cell Non-Hodgkin Lymphoma

MONTREAL, QUEBEC, Sep 13, 2012 (MARKETWIRE via COMTEX) -- Editors note: There is a video…

lauradSeptember 13, 2012

Mon	Tue	Wed	Thu	Fri	Sat	Sun
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

News & Media

Supporting Young Adults with Lymphoma in Canada

Watchful Waiting

Continued Support of Lymphoma Research

Early Detection of Lymphoma in Primary Care

Canadian Institute for Health Research doubles gifts to LC

Celebrating Health Canada’s Approval of ADCETRIS

Bendamustine for treatment of iNHL and MCL

Rituximab and Elderly Mantle Cell Patients

Bendamustine added to BC Drug Benefit List

New Treatment Option for Relapsed Indolent B-cell Non-Hodgkin Lymphoma

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List